The rise in the Zydus Lifesciences shares came after the company received final approval from the United States Food and Drug ...

This new approval is one more milestone for Zydus Group, which has now received 420 USFDA approvals. As of now, the company has made 483 Abbreviated New Drug Applications (ANDAs), having started its ...

Interetingly, on the other hand, the shares of another listed company from the Zydus group witnessed a surge in its prices. In the opening hours of the day's trade, the shares of Zydus Wellness ...

Zydus Lifesciences Limited has received final approval from the United States Food and Drug Administration to manufacture Apalutamide Tablets, 60 mg.

Zydus Lifesciences share price extended the gains ... the company informed that the USFDA conducted a surveillance inspection at the group’s API Unit 1, located at Ankleshwar in Gujarat.

In the year 2003, German Remedies, Recon Healthcare, Zoom Properties and Zydus Pathline merged with the company. Also, they acquired Alpharma France, which spearheaded the group operations in France.

Spooked by US president's threat, several Indian pharma players lobby for blanket duty waiver on drugs coming from America, ...

Indian equity indices ended strong on Friday, with the NIFTY closing at 23,350.40, up 159.75 points (0.69%), while the Sensex ...

Experts underestimated Trump's seriousness on tariffs; Indian auto and pharma sectors brace for impact, while steel remains ...